TXMD
NASDAQ · Pharmaceuticals
Therapeuticsmd Inc
$2.34
+0.05 (+2.18%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+407.7% upside
Low Target
$7.57
Average Target
$11.88
High Target
$17.16
Current Price
$2.34
Current
$2.34
$2.34
Target
$11.88
$11.88
$7.57
$11.88 avg
$17.16
Scenario Analysis
Bear Case
$7.57
223.5%
Low target
Base Case
$11.88
+407.7%
Avg target
Bull Case
$17.16
+633.3%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$2.95
-20.7% from high
52-Week Low
$0.74
+214.3% from low
Target vs 52W High
$11.88
+302.7% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |